Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. - Wikidata - awgldk - TriplyDB

Quality of life three years after diagnosis of localised prostate cancer: population based cohort study.

Quality of life three years after diagnosis of localised prostate cancer: population based cohort study.

http://www.wikidata.org/entity/Q37444820

about

Low-dose rate brachytherapy for men with localized prostate cancer Socioeconomic status and health-related quality of life among patients with prostate cancer 6 months after radical prostatectomy: a longitudinal analysis Development of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset.Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.PROSPECTIV-a pilot trial of a nurse-led psychoeducational intervention delivered in primary care to prostate cancer survivors: study protocol for a randomised controlled trial Clinician-led improvement in cancer care (CLICC)--testing a multifaceted implementation strategy to increase evidence-based prostate cancer care: phased randomised controlled trial--study protocol Prostate cancer outcomes in France: treatments, adverse effects and two-year mortality Validity of using multiple imputation for "unknown" stage at diagnosis in population-based cancer registry data.Living with prostate cancer: randomised controlled trial of a multimodal supportive care intervention for men with prostate cancer.Focal laser interstitial thermotherapy (LITT) at 980 nm for prostate cancer: treatment feasibility in Dunning R3327-AT2 rat prostate tumour.The struggle towards 'the New Normal': a qualitative insight into psychosexual adjustment to prostate cancer.Using linked routinely collected health data to describe prostate cancer treatment in New South Wales, Australia: a validation study A multicomponent theory-based intervention improves uptake of pelvic floor muscle training before radical prostatectomy: a 'before and after' cohort study.Quality-of-life effects of prostate-specific antigen screening.Relationship between lifestyle and health factors and severe lower urinary tract symptoms (LUTS) in 106,435 middle-aged and older Australian men: population-based study.Implementation and scientific evaluation of rehabilitative sports groups for prostate cancer patients: study protocol of the ProRehab Study Recommendations on screening for prostate cancer with the prostate-specific antigen test.Evidence-based guideline recommendations on low-dose rate brachytherapy in patients with low- or intermediate-risk prostate cancer.The validity of the distress thermometer in prostate cancer populations.Systematic review: anal and rectal changes after radiotherapy for prostate cancer.Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review.Defining young in the context of prostate cancer.Establishing a population-based patient-reported outcomes study (PROMs) using national cancer registries across two jurisdictions: the Prostate Cancer Treatment, your experience (PiCTure) study.Prostate cancer mortality outcomes and patterns of primary treatment for Aboriginal men in New South Wales, Australia.Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, Canada An update on the changing indications for androgen deprivation therapy for prostate cancer.The COMPASs Study: Community Preferences for Prostate cAncer Screening. Protocol for a quantitative preference study.Clinical intervals and diagnostic characteristics in a cohort of prostate cancer patients in Spain: a multicentre observational study.A pilot randomised controlled trial of personalised care after treatment for prostate cancer (TOPCAT-P): nurse-led holistic-needs assessment and individualised psychoeducational intervention: study protocol Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy.Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer Small but significant socioeconomic inequalities in axillary staging and treatment of breast cancer in the Netherlands A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease.Nurse-led group consultation intervention reduces depressive symptoms in men with localised prostate cancer: a cluster randomised controlled trial.Distress, delay of gratification and preference for palliative care in men with prostate cancer.Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study Effects of a clinician referral and exercise program for men who have completed active treatment for prostate cancer: A multicenter cluster randomized controlled trial (ENGAGE)Australian patterns of prostate cancer care: Are they evolving?A cluster-randomised, parallel group, controlled intervention study of genetic prostate cancer risk assessment and use of PSA tests in general practice--the ProCaRis study: study protocol Toward ethically responsible choice architecture in prostate cancer treatment decision-making.

P2860

Q24235544-25F3862E-CAB0-4BC1-8177-01B2DC95E1D6 Q24658522-1A73EBA6-E1B2-4062-A41E-072A5F15C20C Q30361302-60581378-EE35-4E8D-9AF3-EEBA2065EE0B Q30878080-2DB68A8C-4286-497A-8AF0-5C1AC0912C84 Q33691464-504A0B93-C364-4262-AACA-D8769EC91704 Q33722746-2D7A5323-0508-4656-A4AD-64E8E80C8A30 Q33795089-F3B3778E-3B18-4B06-AD3C-DB4C19501D39 Q33842354-1810B475-0CB9-4EF6-A8A9-B3FB3BF77AB9 Q33972182-D7390A2F-A9CD-4B55-B61B-41AE0A2033ED Q34012228-F976846A-3A8A-49AE-BF62-8DD31CE020CE Q34013452-1D5B8E25-C6BC-4EA4-8261-45D03F2F3283 Q34041834-64AA28C6-3E05-4813-8197-7B0BAD6C43AE Q34140025-74FF4A16-FAD9-4066-AE28-D6F1E1A8B9CB Q34294102-D2D64227-446E-442D-94FF-7E2B05AD0938 Q34343445-9D3CBB1B-2F3E-472B-8C4D-FA362556DFD0 Q34350120-B2A7C1AA-57B0-4D6F-BC0F-4ACB0BFDADF1 Q34435885-098E3F22-664B-4FA9-96AF-E93396929AB2 Q34795596-D38D4D61-D698-4AB2-A9ED-B1CD1BF6C0FB Q34807091-9D5F3E79-ADD2-40FE-93D6-9455E79A68B8 Q35024218-8A3717D4-C8EF-4FF4-8816-B5B1DEE7D611 Q35079338-5D6B2006-9855-41F1-BD65-7803D53B32E0 Q35181814-C83B389A-DCE0-4788-A8E9-2F51CB9DB9BE Q35466577-67DA0D6B-C2E1-49B0-B246-C44C61440ACC Q35535819-505284D1-A009-4C8E-9EFB-5E9649EBCC07 Q35541638-538B1816-03DC-4CB7-904F-87B4056FE55F Q35549863-9C8E19CA-91A5-43D1-BF8E-14DC982855B9 Q35659835-4FFF9C63-8593-4581-88A3-1931680E9F39 Q35680616-B77C5EEC-E134-4F4C-A236-CF27C0D2FE34 Q35803168-1B68767B-B227-4505-A9D9-AF4DFFFA93B4 Q35812145-13AA7520-E199-4509-A0FD-D04A8AFDDE1C Q35883123-9DD2D15A-4D67-4E9F-8CB9-17FEB0BBFFE7 Q36075221-F4439900-868B-4E2F-BA39-6A3E4823925B Q36096487-123EDB69-BF4C-4A9A-908B-CB578A29D4B0 Q36105114-BB3C3722-AD26-4463-B106-9BE6061DD061 Q36200494-64C06FB7-54E7-4DF2-8326-9E6406BFF991 Q36274021-E066BC08-2440-41C0-A009-27AF6441D83B Q36302706-173F999E-C8E8-4AA2-B45C-C551CA1ED42F Q36680640-17C35B21-5D5B-42D7-A99A-9BA18BD78B38 Q36730143-384D044F-45D7-407F-A4B5-FA17B32E4257 Q36779782-7C1DF040-7450-4071-A74F-02F91D0428F9

P2860

Quality of life three years after diagnosis of localised prostate cancer: population based cohort study.

http://www.wikidata.org/entity/Q37444820

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Quality of life three years af ...... population based cohort study.

@en

Quality of life three years af ...... population based cohort study.

@nl

type

label

Quality of life three years af ...... population based cohort study.

@en

Quality of life three years af ...... population based cohort study.

@nl

prefLabel

Quality of life three years af ...... population based cohort study.

@en

Quality of life three years af ...... population based cohort study.

@nl

P1433

Q37444820-70271CDD-EBCE-48DF-BFCA-31BE7C9D5F0A

P1476

Q37444820-86CBCF57-8E6F-452B-A1FC-5F4A976BB96B

P2093

Q37444820-466CFF2C-9F38-45A8-B082-285A1810DC64

Q37444820-4F6562E5-6670-4B32-96BB-808AFEC7DBAB

Q37444820-9D5564BC-EADA-4DA8-8868-956008608EFA

Q37444820-A2CD29B8-541E-492F-B335-C5AF47664D29

Q37444820-B4DBD17F-AD3D-47A0-B825-F582D2EB561A

Q37444820-B5BA6D43-352D-4841-9773-1EBC3037BE6F

Q37444820-CE4D31F9-BC37-4FFB-AB5D-12773E7D18A5

Q37444820-E214CD5A-287A-4032-8DA9-3866CDC0A9C4

P2860

Q37444820-1159F4D2-ED11-4F5E-A9AA-60C39BD6DBF9

Q37444820-1257F8A2-D40A-4016-A3AF-C099366D560A

Q37444820-1EF57C04-3479-472C-A858-F51513FA7E9F

Q37444820-2459EC67-3FCA-478C-8B45-140FA0BC20F5

Q37444820-2BA3B5D0-552A-40CA-8BEA-96CBC253CF3B

Q37444820-2F4E6F86-5D5A-4AFC-86CC-26516176FB45

Q37444820-2FE8117E-ACA7-454A-9C6F-0977A679AA14

Q37444820-332FCB5A-6E78-44DB-B47A-7BE73AA7172F

Q37444820-3403158D-6694-4329-9072-09A43ACBCE72

Q37444820-418193A5-1FC5-4A4A-8436-4CB7F2D4A7BF

P304

Q37444820-40B842AB-5E76-46C5-92E9-5C861C575DE1

P31

Q37444820-EA85EBBA-A544-46AB-A157-38BE2C4B829F

P356

Q37444820-B41C7D21-477C-4567-BCA1-35D74B66AF5D

P407

Q37444820-40F21CE0-5FDB-4A26-8502-14DFBDA9AA63

P478

Q37444820-740BD805-7641-433C-990F-5BE96F8656B8

P50

Q37444820-67BB1AFB-5309-4EC3-A925-F4C5FF41AB1F

P577

Q37444820-02BE9786-8B25-4600-BFBB-5980FECE16FB

P698

Q37444820-3625E6B1-6AC6-45F2-8303-922BA762E109

P921

Q37444820-42D36D18-409C-4354-96E3-C45DCBF354C4

P932

Q37444820-F76EF4BB-46CF-424C-B296-84D5D2AE170A

P356

P1433

P1476

Quality of life three years af ...... population based cohort study.

@en

P2093

Bruce K Armstrong

http://www.w3.org/2001/XMLSchema#string

David P Smith

http://www.w3.org/2001/XMLSchema#string

Dianne L O'Connell

http://www.w3.org/2001/XMLSchema#string

Jeanette Ward

http://www.w3.org/2001/XMLSchema#string

Madeleine T King

http://www.w3.org/2001/XMLSchema#string

Martin P Berry

http://www.w3.org/2001/XMLSchema#string

Paul Cozzi

http://www.w3.org/2001/XMLSchema#string

Sam Egger

http://www.w3.org/2001/XMLSchema#string

P2860

Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE.

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Prostate cancer and health-related quality of life: a review of the literature.

Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be diffic

The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups.

Quality of life after therapy for localized prostate cancer.

Active surveillance for early-stage prostate cancer: review of the current literature.

EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century.

Age, health, and education determine supportive care needs of men younger than 70 years with prostate cancer.

P304

b4817

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.B4817

http://www.w3.org/2001/XMLSchema#string

P407

P478

339

http://www.w3.org/2001/XMLSchema#string

P50

Phillip D Stricker

P577

2009-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19945997

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

P932

2784818

http://www.w3.org/2001/XMLSchema#string